Babita SHASHNI, Ph.D.
Nagasaki Laboratory, Department of Material Science, Graduate School of Pure and AppliedSciences, University of Tsukuba, Tsukuba, Tennodai 1-1-1, Ibaraki, Japan (305-8573)
E-mail: shashni@ims.tsukuba.ac.jp
Tel (Office): +81029-853-5936---------------------------------------------------------------------------------------------------------------------Education
2011/08 – 2014/07: Ph.D., Biotechnology (Bioindustrial Sciences)
Graduate School of Life and Environmental Sciences, University of Tsukuba, Tsukuba, Ibaraki,
Japan.
2008/08 – 2010/05: M.S., Biotechnology
Department of Biotechnology, Guru Nanak Dev University, Punjab, India.
2005/04 – 2008/04: B.S. (Honours), BiotechnologyG.C.G, Sector- 42, Punjab University, Chandigarh, India
Professional/Research experience
2020/06 – present: Specially appointed assistant professor
Department of Material Science, Graduate School of Pure and Applied Sciences, University ofTsukuba, Tsukuba, Ibaraki, Japan
2018/05 – 2020/05: Postdoctoral fellow
Department of Material Science, Graduate School of Pure and Applied Sciences, University ofTsukuba, Tsukuba, Ibaraki, Japan
2015/10 – 2018/03: Postdoctoral fellow
Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan.
2016/04 – 2018/03: Visiting researcher
Department of Material Science, Graduate School of Pure and Applied Sciences, University ofTsukuba, Japan.
2015/10 – 2016/03: Research assistant
Department of Material Science, Graduate School of Pure and Applied Sciences, University ofTsukuba, Tsukuba, Ibaraki, Japan.
2014/08 – 2015/09: Postdoctoral fellow
Department of Material Science, Graduate School of Pure and Applied Sciences, University ofTsukuba, Tsukuba, Ibaraki, Japan.

1

Publication list
1. Babita Shashni*, and Yukio Nagasaki* (2021), “Newly developed self-assembling
antioxidants as potential therapeutics for the cancers”, J Pers Med., Vol. 11(2), pp. 92.
2. Babita Shashni, Yuji Nishikawa, Yukio Nagasaki (2021), “Management of tumor growth
and angiogenesis in triple-negative breast cancer by using redox nanoparticles”, Biomaterials,Vol. 269,12064.
3. Ting Mei, Babita Shashni, Hiroshi Maeda, Yukio Nagasaki (2020), “Fibrinolytic tissue
plasminogen activator installed redox-active nanoparticles (t-PA@iRNP) for cancer therapy”,
Biomaterials, Vol. 259,120290.
4. Babita Shashni, Hidehiko Matsuura, Riku Saito, Takuma Hirata, Shinya Ariyasu, KentaNomura, Hiroshi Takemura, Kazunori Akimoto, Naoyuki Aikawa, Atsuo Yasumori and ShinAoki (2018), “Simple and convenient method for the isolation, culture, and re-collection ofcancer cells from blood by using glass-bead filters”, ACS Biomaterials Science &Engineering (Methods/Protocols),Vol. 52, pp.438-452.
5. Abdullah-Al Masum, Kenta Yokoi, Yosuke Hisamatsu, Kana Naito, Babita Shashni, andShin Aoki (2018), “Design and synthesis of a luminescent iridium complex-peptide hybrid(IPH) that detects cancer cells and induces their apoptosis”, Bioorganic & MedicinalChemistry, Vol. 26(17), pp. 4804-4816.
6. Babita Shashni and Yukio Nagasaki (2018), Nitroxide radical-containing nanoparticles
attenuate tumorigenic potential of triple negative breast cancer”, Biomaterials. Vol. 178, pp.
48-62.
7. Babita Shashni, Shinya Ariyasu, Reisa Takeda, Toshihiro Suzuki, Shota Shiina, KazunoriAkimoto, Takuto Maeda, Naoyuki Aikawa, Ryo Abe, Tomohiro Osaki, Norihiko Itoh, andShin Aoki (2018), “Size-based differentiation of cancer and normal cells by a particle size
analyzer assisted by a cell-recognition PC Software,’’ Biol. Pharm. Bull. Vol. 41(4), pp.
487-503.
8. Babita Shashni*, Yukichi Horiguchi*, Kosuke Kurosu, Hitoshi Furusho, Y ukio Nagasaki(2017), “Application of surface enhanced Raman spectroscopy as a diagnostic system for
hypersialylated metastatic cancers”, Biomaterials, Vol. 134, pp. 143-153.
9. Babita Shashni, Abdulaziz Alshwimi, Kentaro Minami, Tatsuhiko Furukawa and Yukio
Nagasaki (2017), “Nitroxide radical-containing nanoparticles as potential candidates forovercoming drug resistance in epidermoid cancers,” Polymer, Vol. 116, pp.429-438.
10. Babita Shashni, Karun Sharma, Rumani Singh, Kishore R. Sakharkar, Sarinder K. Dhillon,Yukio Nagasaki and Meena K. Sakharkar (2013), “Coffee component Hydroxyl
Hydroquinone (HHQ) as a putative ligand for PPAR gamma and implications in breastcancer,” BMC Genomics, Vol.14 (Suppl 5):S6.
11. Meena K. Sakharkar*, Babita Shashni*, Karun Sharma, Sarinder K. Dhillon, Prabhakar R.
Ranjekar and Kishore R. Sakharkar* (2013), “Therapeutic implications of targeting energy
metabolism in breast cancer,” PPAR Research, Vol. 2013: Article ID 109285, 11.
12. Babita Shashni, Kishore R. Sakharkar, Yukio Nagasaki and Meena K. Sakharkar (2012),“The glycolytic enzymes PGK1 and PKM2 as novel transcriptional targets of PPAR gamma
in breast cancer pathophysiology,” Journal of Drug Targeting, Vol. 21(2), pp. 161-174.
“ * ” Authors contributed equally2